[144] ARTIVION, INC. SEC Filing

Rhea-AI Filing Summary

The notice reports a planned sale of 4,200 shares of common stock of AORT by a holder under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $189,413.28 and an approximate sale date of 11/18/2025. These shares were acquired as restricted stock from the issuer on 06/06/2024, with no separate cash payment described. As context, the filing states that 47,374,939 shares of the issuer’s common stock were outstanding at the time referenced.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4200	189413.28	47374939	11/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/06/2024	Restricted Stock	Issuer			4200	06/06/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AORT's latest Form 144 filing disclose?

The Form 144 discloses that a holder intends to sell 4,200 shares of AORT common stock under Rule 144 through a broker on the NYSE.

How many AORT shares are planned to be sold and what is their market value?

The holder plans to sell 4,200 common shares of AORT with an indicated aggregate market value of $189,413.28 at the time referenced in the filing.

When and where will the AORT shares in this Form 144 likely be sold?

The filing lists an approximate sale date of 11/18/2025 and states that the NYSE is the securities exchange on which the 4,200 shares are to be sold.

How were the AORT shares in this Form 144 originally acquired?

The 4,200 shares were acquired as restricted stock from the issuer on 06/06/2024, with the nature of payment described as not applicable.

Who is the broker for the planned AORT share sale in this Form 144?

The planned sale of 4,200 AORT common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, New York.

How many AORT shares were outstanding according to the Form 144 filing?

The filing states that there were 47,374,939 shares of AORT common stock outstanding as of the time referenced, providing a baseline for the issuer's share count.